FI910497A0 - Nytt virus vid infektioes bursalsjukdom. - Google Patents

Nytt virus vid infektioes bursalsjukdom.

Info

Publication number
FI910497A0
FI910497A0 FI910497A FI910497A FI910497A0 FI 910497 A0 FI910497 A0 FI 910497A0 FI 910497 A FI910497 A FI 910497A FI 910497 A FI910497 A FI 910497A FI 910497 A0 FI910497 A0 FI 910497A0
Authority
FI
Finland
Prior art keywords
virus
infektioes
bursalsjukdom
nytt
vid
Prior art date
Application number
FI910497A
Other languages
English (en)
Other versions
FI100383B (fi
Inventor
David B Snyder
Original Assignee
Univ Maryland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Maryland filed Critical Univ Maryland
Publication of FI910497A0 publication Critical patent/FI910497A0/fi
Priority to FI972658A priority Critical patent/FI101603B1/fi
Application granted granted Critical
Publication of FI100383B publication Critical patent/FI100383B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/10011—Birnaviridae
    • C12N2720/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/816—Viral vaccine for avian species, e.g. poultry or other birds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FI910497A 1988-08-02 1991-02-01 Menetelmä ja testipakkaus siipikarjan bursaalitautia indusoivan viruks en havaitsemiseksi FI100383B (fi)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI972658A FI101603B1 (fi) 1988-08-02 1997-06-19 Menetelmä rokotteen valmistamiseksi siipikarjan tarttuvaa bursaalitautia vastaan

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US07/227,311 US5064646A (en) 1988-08-02 1988-08-02 Novel infectious bursal disease virus
US22731188 1988-08-02
PCT/US1989/003286 WO1990001336A1 (en) 1988-08-02 1989-08-02 Novel infectious bursal disease virus
US8903286 1989-08-02

Publications (2)

Publication Number Publication Date
FI910497A0 true FI910497A0 (fi) 1991-02-01
FI100383B FI100383B (fi) 1997-11-28

Family

ID=22852607

Family Applications (1)

Application Number Title Priority Date Filing Date
FI910497A FI100383B (fi) 1988-08-02 1991-02-01 Menetelmä ja testipakkaus siipikarjan bursaalitautia indusoivan viruks en havaitsemiseksi

Country Status (12)

Country Link
US (1) US5064646A (fi)
EP (1) EP0428596B1 (fi)
JP (1) JP3148214B2 (fi)
KR (1) KR900701314A (fi)
AT (1) ATE136788T1 (fi)
AU (1) AU631808B2 (fi)
CA (1) CA1340931C (fi)
DE (1) DE68926300T2 (fi)
FI (1) FI100383B (fi)
NZ (1) NZ230148A (fi)
WO (1) WO1990001336A1 (fi)
ZA (1) ZA895867B (fi)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5192539A (en) * 1988-07-21 1993-03-09 Akzo N.V. Infectious bursal disease virus production in continuous cell lines
US5518724A (en) * 1988-08-02 1996-05-21 University Of Maryland Infectious bursal disease virus
US5632989A (en) * 1989-10-18 1997-05-27 University Of Maryland Attenuated, live vaccine for Delaware strain IBDV
NZ235474A (en) * 1989-10-18 1992-12-23 Univ Maryland Virus capable of inducing infectious bursal disease; assay and vaccine
US5595912A (en) * 1990-05-04 1997-01-21 University Of Maryland College Park Specific DNA and RNA sequences associated with US IBDV variants, vector carrying DNA sequences, host carrying cloned vector, deduced amino acid sequences, vaccine and method of vaccination
IL103939A (en) * 1992-12-01 1996-09-12 Abic Ltd An anti-DBI vaccine in birds containing attenuated live DBI virus
DK1037927T3 (da) 1997-12-08 2004-09-06 Emd Lexigen Res Ct Corp Heterodimere fusionsproteiner, der er nyttige til målrettet immunterapi og generel immunstimulering
SK782002A3 (en) 1999-07-21 2003-08-05 Lexigen Pharm Corp FC fusion proteins for enhancing the immunogenicity of protein and peptide antigens
JP5179689B2 (ja) 2000-02-11 2013-04-10 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング 抗体ベース融合タンパク質の循環系内半減期の増強
DK1366067T3 (da) 2001-03-07 2012-10-22 Merck Patent Gmbh Ekspressionsteknologi for proteiner indeholdende en hybrid isotype-antistof-enhed
WO2002079415A2 (en) 2001-03-30 2002-10-10 Lexigen Pharmaceuticals Corp. Reducing the immunogenicity of fusion proteins
CA2446087C (en) 2001-05-03 2013-06-18 Stephen D. Gillies Recombinant tumor specific antibody and use thereof
EP1454138B1 (en) 2001-12-04 2012-01-18 Merck Patent GmbH Immunocytokines with modulated selectivity
US20040146530A1 (en) * 2002-01-30 2004-07-29 Sharma Jagdev M Avian vaccine effective against infectious bursal disease virus
ATE471946T1 (de) 2002-12-17 2010-07-15 Merck Patent Gmbh Humanisierter antikörper (h14.18) des maus antikörpers 14.18, der gd2 bindet und seine fusion mit il-2
WO2005049077A2 (en) * 2003-11-17 2005-06-02 Regents Of The University Of Minnesota Avian vaccine effective against infectious bursal disease virus
BRPI0418286A (pt) 2003-12-30 2007-05-02 Merck Patent Gmbh proteìnas de fusão de il-7
ES2330860T3 (es) 2004-01-22 2009-12-16 Merck Patent Gmbh Anticuerpos anticancerosos con fijacion del complemento reducida.
US7670595B2 (en) 2004-06-28 2010-03-02 Merck Patent Gmbh Fc-interferon-beta fusion proteins
CN100360662C (zh) * 2004-09-27 2008-01-09 长江大学 一种传染性法氏囊病基因工程亚单位疫苗的制备方法和应用
US7244432B2 (en) * 2004-12-08 2007-07-17 University Of Maryland Biotechnology Institute Infectious bursal disease virus (IBDV) variant from Georgia
CA2635623C (en) 2005-12-30 2015-02-17 Michael Super Anti-cd19 antibodies with reduced immunogenicity
DK1966238T3 (da) 2005-12-30 2012-07-16 Merck Patent Gmbh INTERLEUKIN-12P40-varianter med forbedret stabilitet
SG175233A1 (en) 2009-04-22 2011-11-28 Merck Patent Gmbh Antibody fusion proteins with modified fcrn binding sites

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4530831A (en) * 1982-11-02 1985-07-23 Akzo N.V. Infectious Bursal Disease vaccine
US4824668A (en) * 1987-03-09 1989-04-25 Sterwin Laboratories Inc. Attenuated infectious bursal disease virus strain and vaccine therefrom
US5192539A (en) * 1988-07-21 1993-03-09 Akzo N.V. Infectious bursal disease virus production in continuous cell lines

Also Published As

Publication number Publication date
NZ230148A (en) 1993-01-27
ATE136788T1 (de) 1996-05-15
EP0428596A4 (en) 1991-09-04
EP0428596A1 (en) 1991-05-29
KR900701314A (ko) 1990-12-01
JP3148214B2 (ja) 2001-03-19
EP0428596B1 (en) 1996-04-17
WO1990001336A1 (en) 1990-02-22
US5064646A (en) 1991-11-12
DE68926300D1 (de) 1996-05-23
AU631808B2 (en) 1992-12-10
DE68926300T2 (de) 1996-10-31
CA1340931C (en) 2000-03-21
ZA895867B (en) 1990-05-30
AU4055989A (en) 1990-03-05
JPH04503153A (ja) 1992-06-11
FI100383B (fi) 1997-11-28

Similar Documents

Publication Publication Date Title
FI910497A0 (fi) Nytt virus vid infektioes bursalsjukdom.
BR9306984A (pt) Análogo de antígeno de peptídeo de um antígeno de peptídeo nativo vacina anticorpo processo para vacinar um hospedeiro necessitando deste tratamento estojo diagnóstico processos para preparar um análogo de um antiígeno de um antígeno de peptídeo nativo para preparar uma vacina para analisar uma amostra para um antígeno de peptídeo nativo e para analisar uma amostra para um anticorpo
FI870447A (fi) Htlv-iii-hoeljepeptider.
BR0207067A (pt) Método para identificar, isolar e produzir antìgenos para um patógeno especìfico e uso do mesmo
ATE125821T1 (de) Vakzin gegen hepatitis b.
ES2095258T3 (es) Nuevo virus de la enfermedad de la bolsa infecciosa.
DE3585370D1 (de) Kreuzreaktive und schuetzende epitope von circumsporozoit-proteinen.
DE69301733T2 (de) Impfstoffe gegen Metazoen-Parasiten
DK1077999T3 (da) Moraxella catarrhalis-proteiner
SE7910089L (sv) Vacciner
DK0396193T3 (da) Hundekoronavirusvaccine
AR020852A1 (es) Antigenos de vacuna de leptospira para la prevencion de leptospirosis
FI972658A (fi) Menetelmä rokotteen valmistamiseksi siipikarjan tarttuvaa bursaalitautia vastaan
DK0524421T3 (da) Humant herpesvirus type 6 protein p 100, de tilsvarende DNA-sekvenser, deres fremstilling og anvendelse
GB2314560A (en) Synthetic peptides of m. gallisepticum, antibodies thereto, their preparations and use
ATE100859T1 (de) Durch virusneutralisierende und schuetzende monokonale antikoerper erkanntes ibdv vp2 epitop.
SE8701294D0 (sv) Hiv-peptid
ATE86500T1 (de) Abgeschwaechtes virus und impfstoffe davon zur verwendung gegen infektionen bei gefluegel, verursacht durch truthahn-rhinotracheitis-virus.
DE9117146U1 (de) Impfstoffe gegen virale Antigene
DE69033316T2 (de) Synthetische Antigene zum Nachweis von Antikörpern gegen Hepatitis C Virus